跳至主要内容
临床试验/NCT02439151
NCT02439151已完成不适用

New Lung Ventilation Strategies Guided by Transpulmonary Pressure in VV-ECMO for Severe ARDS

Rui Wang1 个研究点 分布在 1 个国家目标入组 104 人开始时间: 2015年5月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
104
试验地点
1
主要终点
Proportion weaned from VV-ECMO

研究概览

简要总结

Extracorporeal membrane oxygenation (ECMO) has been widely used in patients with severe acute respiratory distress syndrome (ARDS). But how to choose mechanical ventilation strategy is still not clear for severe ARDS patients supported by ECMO. Our previous work found that, compared to the traditional "lung rest" strategy, transpulmonary pressure guide new lung ventilation strategy can better maintain lung volume reduction lung collapse, atelectasis occurs. The severe ARDS patients receiving ECMO therapy were randomized divided into a new ventilation strategy group and the conventional ventilation strategy group. The new ventilation strategy is transpulmonary pressure guide ventilator setting method, and the conventional ventilation strategy is Extracorporeal Life Support Organization (ELSO) guide ventilation method. Compare the difference between the two groups of patients in lung injury, and explore the lung protection mechanism of new lung ventilation strategies guided by transpulmonary pressure. Our research group considered that transpulmonary pressure guide new lung ventilation strategy can provide more effective lung protection. And it will be further used in clinical work.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ARDS cause reversible;
  • Pure oxygen is given, but PaO2/FiO2<80;
  • P(A-a)O2>600mmHg;
  • Murray score≥3.0;

排除标准

  • peak inspiratory pressure>30cmH2O;
  • high FiO2>0.8;
  • ventilation>7 days;
  • contraindication to heparinization;
  • non-reversible central nervous system injury
  • chronic disease with a short life expectancy

结局指标

主要结局

Proportion weaned from VV-ECMO

时间窗: After patients randomized grouping 60 days

Respiratory failure was alleviated and then ECMO withdrawal could be considered

次要结局

  • 60-day mortality(After patients randomized grouping 60 days)

研究者

发起方
Rui Wang
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Rui Wang

Principal Investigator

Beijing Chao Yang Hospital

研究点 (1)

Loading locations...

相似试验

New Lung Ventilation Strategies Guided by... | 临床试验